查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1790250

伴侶動物骨關節炎市場規模、佔有率和趨勢分析報告：按產品、動物、給藥途徑、最終用途、地區和細分市場預測，2025 年至 2033 年

Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product, By Animal, By Route Of Administration, By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

伴侶動物骨關節炎市場概覽

2024 年全球伴侶動物骨關節炎市場規模估計為 22.9 億美元，預計到 2033 年將達到 132.7 億美元，2025 年至 2033 年的複合年成長率為 23.5%。預計推動市場發展的關鍵因素包括骨關節炎盛行率上升、研發舉措增加、新治療方法出現、宣傳宣傳活動增加以及由於診斷技術的進步而導致的骨關節炎 (OA) 治療的採用率增加。

伴侶動物（尤其是犬、貓和馬）中骨關節炎 (OA) 的盛行率不斷上升，是全球伴侶動物骨關節炎市場的主要驅動力。僅就犬類而言，根據臨床觀察和影像學檢查結果，估計約有 20% 的 1 歲以上犬會出現 OA 的臨床症狀，而老年犬的盛行率可能高達 80%。貓類也呈現類似的趨勢，雖然 OA 通常未被充分診斷，但在老年貓科動物群中，這一現象正日益受到重視。一些研究表明，高達 90% 的 12 歲以上貓會出現 OA 的影像學症狀。馬類的 OA 也是運動馬匹和賽馬表現下降和提前退休的主要原因。

導致骨關節炎盛行率不斷上升的因素有很多，包括由於營養和獸醫護理的進步而延長的寵物壽命、不斷上升的肥胖率（骨關節炎的主要風險因素），以及獸醫和飼主的認知度和診斷能力的提高。這些趨勢推動了對早期診斷、慢性病管理和疼痛緩解解決方案的需求。

日益加重的負擔促使骨關節炎（OA）治療領域出現大量投資和創新，包括開發新型生技藥品、再生療法（例如幹細胞和富血小板血漿）、單株抗體（例如碩騰的Librela和Solensia）以及其他複雜的疼痛管理方法。製藥和生物技術公司正在積極開發長效標靶治療，以提高寵物的依從性並改善其生活品質，尤其是在寵物飼主對高階預防保健的需求日益成長的情況下。同時，獸醫就診次數的激增以及對運動監測和健康計劃的日益重視，推動了診斷藥物、補充劑、關節支持飲食和復健服務市場的強勁成長。

綜合起來，這些流行病學和行為因素不僅擴大了伴侶動物骨關節炎患者的數量，而且還使該疾病成為全球動物保健行業的關鍵領域，為治療、診斷和支持性護理解決方案提供了長期成長機會。

儘管在市場上取得了巨大成功並被廣泛採用，但像 Librela 這樣的針對骨關節炎的單株抗體最近面臨著公眾爭議，包括要求徹底禁止的呼聲和表明肌肉骨骼不利事件增加九倍的新數據，這帶來了聲譽和監管挑戰。 FDA 和 EMA 等監管機構加強審查可能會導致更嚴格的上市後監控、標籤修訂和配方限制。短期內，獸醫和寵物飼主可能會轉向更保守的選擇，例如現有的非類固醇消炎劑和補充劑，這可能會減緩生技藥品領域的成長。然而，透明的安全測試、改進的藥物安全檢測和明確的風險效益指南可以恢復信心，並最終鞏固 mAb 療法作為骨關節炎治療的地位。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章：伴侶動物骨關節炎市場的趨勢與展望

  • 市場體系展望
    • 母市場
    • 子公司市場
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
    • 市場機會分析
    • 市場問題分析
  • 伴侶動物骨關節炎市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
    • 主要國家的法規結構
    • 按主要國家和物種分類的動物族群估計數（2021-2024 年）
    • 管道/臨床實驗室分析
    • COVID-19影響分析

第4章 伴侶動物骨關節炎市場：產品、估計與趨勢分析

  • 細分儀表板
  • 伴侶動物骨關節炎市場：產品差異分析
  • 伴侶動物骨關節炎市場規模與趨勢分析（按產品分類）（2021-2033 年）
  • 生技藥品
    • 幹細胞
    • 富血小板血漿（platelet-richplasma）
    • 單株抗體（mAb）
    • 其他生技藥品
  • 黏稠補充劑
  • 製藥
    • 類固醇
    • NSAIDs
    • 其他
  • 營養補充品

第5章 伴侶動物骨關節炎市場：依物種的估計與趨勢分析

  • 細分儀表板
  • 伴侶動物骨關節炎市場：動物變異分析
  • 伴侶動物骨關節炎市場規模與趨勢分析（按動物，2021-2033 年）
  • 狗
  • 貓
  • 馬

6. 伴侶動物骨關節炎市場：依給藥途徑的估計與趨勢分析

  • 細分儀表板
  • 伴侶動物骨關節炎市場：給藥途徑變異分析
  • 伴侶動物骨關節炎市場規模與趨勢分析（依管理途徑，2021-2033 年）
    • 口服
    • 注射
    • 肌肉注射
    • 關節內
    • 其他注射藥物
    • 其他

7. 伴侶動物骨關節炎市場：最終用途、估計與趨勢分析

  • 細分儀表板
  • 伴侶動物骨關節炎市場：最終用途差異分析
  • 2021 年至 2033 年伴侶動物骨關節炎市場規模與趨勢分析（依最終用途）
    • 獸醫院/診所
    • 電子商務
    • 其他

8. 伴侶動物骨關節炎市場：區域、估計與趨勢分析

  • 區域儀表板
  • 2024 年及 2033 年伴侶動物骨關節炎市場佔有率
  • 區域展望
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭態勢

  • 市場參與企業分類
  • 企業市場分析/堆圖分析
  • 公司簡介
    • Zoetis
    • Boehringer Ingelheim
    • Elanco Animal Health
    • American Regent, Inc.
    • Merck Animal Health（Merck & Co. Inc）
    • Vetoquinol SA
    • Ceva Sante Animale
    • Virbac
    • Biogenesis Bago
    • Ardent Animal Health, Llc
    • PetVivo Holdings, Inc.（Spryng）
    • VetStem Inc.
    • Enso Discoveries
    • Contura Vet US
    • T-Cyte Therapeutics
    • Medrego Llc.
  • 戰略地圖
    • 合併與收購
  • 夥伴關係和合作
  • 擴張
  • 產品發布
  • 產品核可
  • 其他
  • 主要企業名單
    • 製造商列表
    • 經銷商名單
    • Product Code: GVR-4-68040-667-6

    Companion Animal Osteoarthritis Market Summary

    The global companion animal osteoarthritis market size was estimated at USD 2.29 billion in 2024 and is projected to reach USD 13.27 billion by 2033, growing at a CAGR of 23.5% from 2025 to 2033. Key factors expected to drive the market include the rising prevalence of osteoarthritis, increasing R&D initiative, emerging novel treatments, increasing awareness campaigns, and advancing diagnostic techniques increasing adoption of osteoarthritis (OA) treatment.

    The rising prevalence of osteoarthritis (OA) in companion animals-particularly dogs, cats, and horses-is significantly driving the global companion animal osteoarthritis market. In canines alone, estimates suggest that approximately 20% of dogs over one year of age show clinical signs of OA, and this prevalence can escalate to as high as 80% in older dogs, according to both clinical observations and radiographic studies. Similar trends are observed in felines, where OA is often underdiagnosed but increasingly recognized in aging cat populations, with some studies indicating radiographic signs in up to 90% of cats over 12 years old. Equine OA also remains a leading cause of reduced performance and early retirement, especially in sport and racehorses.

    Several factors are contributing to this increase in OA prevalence, including extended pet lifespans due to advances in nutrition and veterinary care, rising rates of obesity (a major OA risk factor), and improved awareness and diagnostic capabilities among veterinarians and pet owners. These trends are expanding the demand for early diagnosis, chronic disease management, and pain relief solutions.

    This growing burden has catalyzed significant investment and innovation in OA therapeutics, including the development of novel biologics, regenerative therapies (e.g., stem cells and PRP), monoclonal antibodies (such as Zoetis' Librela and Solensia), and other multimodal pain management approaches. Pharmaceutical and biotech companies are actively developing long-acting, targeted therapies that offer better compliance and improved quality of life for pets, particularly as pet owners increasingly seek premium and preventative care. In parallel, the surge in veterinary visits and emphasis on mobility monitoring and wellness programs is reinforcing a robust market for diagnostics, supplements, joint-support diets, and rehabilitation services.

    Altogether, these epidemiological and behavioral factors are not only expanding the companion animal OA patient pool but are also transforming the disease into a cornerstone segment of the global animal health industry-creating long-term growth opportunities across therapeutics, diagnostics, and supportive care solutions.

    Despite strong market performance and widespread adoption of OA-targeting monoclonal antibodies like Librela, the recent public controversy-including calls for outright bans and new data suggesting a nine fold increase in musculoskeletal adverse events-poses a reputational and regulatory challenge. Heightened scrutiny from regulators like the FDA and EMA may result in tougher post market surveillance, label revisions, or prescribing restrictions. In the short term, veterinarians and pet owners might pivot toward more conservative options, such as established NSAIDs or supplements, potentially slowing growth in the biologics segment. However, transparent safety studies, improved pharmacovigilance, and clear risk-benefit guidelines could restore confidence and ultimately solidify the position of mAb therapies as a premium OA treatment-assuming manufacturers respond proactively

    Global Companion Animal Osteoarthritis Market Report Segmentation

    This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the companion animal osteoarthritis market report based on product, animal, route of administration, end use, and region:

    • Product Outlook (Revenue, USD Million, 2021 - 2033)
    • Biologics
      • Stem Cells
      • Platelet-Rich Plasma (PRP)
      • Monoclonal Antibodies (mAb)
      • Other Biologics
    • Viscosupplements
    • Pharmaceuticals
      • Steroids
      • NSAIDS
      • Others
    • Nutritional Supplements
    • Animal Outlook (Revenue, USD Million, 2021 - 2033)
    • Canine
    • Equine
    • Feline
    • Route of Administration Outlook (Revenue, USD Million, 2021 - 2033)
    • Oral
    • Injectable
      • Intra-muscular
      • Intra-articular
      • Other Injectable
    • Others
    • End Use Outlook (Revenue, USD Million, 2021 - 2033)
    • Veterinary Hospitals/Clinics
    • E-commerce
    • Others
    • Regional Outlook (Revenue, USD Million, 2021 - 2033)
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Denmark
      • Sweden
      • Norway
    • Asia Pacific
      • Japan
      • India
      • China
      • South Korea
      • Australia
      • Thailand
    • Latin America
      • Brazil
      • Argentina
    • Middle East and Africa (MEA)
      • South Africa
      • Saudi Arabia
      • UAE
      • Kuwait

    Table of Contents

    Chapter 1. Methodology and Scope

    • 1.1. Market Segmentation and Scope
    • 1.2. Research Methodology
    • 1.3. Information Procurement
      • 1.3.1. Purchased Database
      • 1.3.2. GVR's Internal Database
      • 1.3.3. Secondary Sources
      • 1.3.4. Primary Research
    • 1.4. Information/Data Analysis
    • 1.5. Market Formulation & Visualization
    • 1.6. Data Validation & Publishing
    • 1.7. Model Details
      • 1.7.1. Commodity flow analysis
      • 1.7.2. Global Market: CAGR Calculation
    • 1.8. List of Secondary Sources

    Chapter 2. Executive Summary

    • 2.1. Market Outlook
    • 2.2. Segment Outlook
    • 2.3. Competitive Insights

    Chapter 3. Companion Animal Osteoarthritis Market Variable Trends & Scope

    • 3.1. Market Lineage Outlook
      • 3.1.1. Parent Market
      • 3.1.2. Ancillary Market
    • 3.2. Market Dynamics
      • 3.2.1. Market Driver Analysis
        • 3.2.1.1. Rising Prevalence of Osteoarthitis
        • 3.2.1.2. Increasing R&D Initiatives
        • 3.2.1.3. Emerging Novel Treatments
        • 3.2.1.4. Increasing Awareness Campaigns
        • 3.2.1.5. Advancing Diagnostic Techniques Increasing Adoption of OA Treatment
      • 3.2.2. Market Restraint Analysis
        • 3.2.2.1. Regulatory Hurdles
        • 3.2.2.2. Emerging Adverse Drug Reactions (ADR)
        • 3.2.2.3. Stringent Regulations
      • 3.2.3. Market Opportunity Analysis
      • 3.2.4. Market Challenge Analysis
    • 3.3. Companion Animal Osteoarthritis Market Analysis Tools
      • 3.3.1. Industry Analysis - Porter's
        • 3.3.1.1. Bargaining power of suppliers
        • 3.3.1.2. Bargaining power of buyers
        • 3.3.1.3. Threat of substitution
        • 3.3.1.4. Threat of new entrants
        • 3.3.1.5. Competitive rivalry
      • 3.3.2. PESTEL Analysis
        • 3.3.2.1. Political & Legal landscape
        • 3.3.2.2. Economic and Social landscape
        • 3.3.2.3. Technological landscape
        • 3.3.2.4. Environmental landscape
      • 3.3.3. Regulatory Framework by Key Countries
      • 3.3.4. Estimated Animal Population, by Key Species, by Key Countries, 2021-2024
      • 3.3.5. Pipeline/ Clinical Trials Analysis
      • 3.3.6. COVID-19 Impact Analysis

    Chapter 4. Companion Animal Osteoarthritis Market: Product Estimates & Trend Analysis

    • 4.1. Segment Dashboard
    • 4.2. Companion Animal Osteoarthritis Market: Product Movement Analysis
    • 4.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
    • 4.4. Biologics
      • 4.4.1. Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.2. Stem Cells
        • 4.4.2.1. Stem Cells Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.3. Platelet-Rich Plasma (PRP)
        • 4.4.3.1. Platelet-Rich Plasma (PRP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.4. Monoclonal Antibodies (mAb)
        • 4.4.4.1. Monoclonal Antibodies (mAb) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.4.5. Other Biologics
        • 4.4.5.1. Other Biologics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5. Viscosupplements
      • 4.5.1. Viscosupplements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.6. Pharmaceuticals
      • 4.6.1. Pharmaceuticals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.2. Steroids
        • 4.6.2.1. Steroids Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.3. NSAIDs
        • 4.6.3.1. NSAIDs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.6.4. Others
        • 4.6.4.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.7. Nutritional Supplements
      • 4.7.1. Nutritional Supplements Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

    Chapter 5. Companion Animal Osteoarthritis Market: Animal Estimates & Trend Analysis

    • 5.1. Segment Dashboard
    • 5.2. Companion Animal Osteoarthritis Market: Animal Movement Analysis
    • 5.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by animal, 2021 to 2033 (USD Million)
    • 5.4. Canine
      • 5.4.1. Canine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.5. Feline
      • 5.5.1. Feline Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 5.6. Equine
      • 5.6.1. Equine Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

    Chapter 6. Companion Animal Osteoarthritis Market: By Route of Administration Estimates & Trend Analysis

    • 6.1. Segment Dashboard
    • 6.2. Companion Animal Osteoarthritis Market: By Route of Administration Movement Analysis
    • 6.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by route of administration, 2021 to 2033 (USD Million)
      • 6.3.1. Oral
        • 6.3.1.1. Oral Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.2. Injectables
        • 6.3.2.1. Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.3. Intra-muscular
        • 6.3.3.1. Intra-muscular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.4. Intra-articular
        • 6.3.4.1. Intra-articular Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.5. Other Injectables
        • 6.3.5.1. Other Injectables Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 6.3.6. Others
        • 6.3.6.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

    Chapter 7. Companion Animal Osteoarthritis Market: By End Use Estimates & Trend Analysis

    • 7.1. Segment Dashboard
    • 7.2. Companion Animal Osteoarthritis Market: By End Use Movement Analysis
    • 7.3. Companion Animal Osteoarthritis Market Size & Trend Analysis, by end use, 2021 to 2033 (USD Million)
      • 7.3.1. Veterinary Hospitals/Clinics
        • 7.3.1.1. Veterinary Hospitals/Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.3.2. E-commerce
        • 7.3.2.1. E-commerce Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 7.3.3. Others
        • 7.3.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

    Chapter 8. Companion Animal Osteoarthritis Market: Regional Estimates & Trend Analysis

    • 8.1. Regional Dashboard
    • 8.2. Companion Animal Osteoarthritis Market Share, By Region, 2024 & 2033 (USD Million)
    • 8.3. Regional Outlook
    • 8.4. North America
      • 8.4.1. North America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.2. U.S.
        • 8.4.2.1. Key Country Dynamics
        • 8.4.2.2. U.S. Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.3. Canada
        • 8.4.3.1. Key Country Dynamics
        • 8.4.3.2. Canada Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.4.4. Mexico
        • 8.4.4.1. Key Country Dynamics
        • 8.4.4.2. Mexico Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.5. Europe
      • 8.5.1. Europe Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.2. UK
        • 8.5.2.1. Key Country Dynamics
        • 8.5.2.2. UK Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.3. Germany
        • 8.5.3.1. Key Country Dynamics
        • 8.5.3.2. Germany Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.4. France
        • 8.5.4.1. Key Country Dynamics
        • 8.5.4.2. France Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.5. Italy
        • 8.5.5.1. Key Country Dynamics
        • 8.5.5.2. Italy Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.6. Spain
        • 8.5.6.1. Key Country Dynamics
        • 8.5.6.2. Spain Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.7. Denmark
        • 8.5.7.1. Key Country Dynamics
        • 8.5.7.2. Denmark Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.8. Sweden
        • 8.5.8.1. Key Country Dynamics
        • 8.5.8.2. Sweden Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.5.9. Norway
        • 8.5.9.1. Key Country Dynamics
        • 8.5.9.2. Norway Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.6. Asia Pacific
      • 8.6.1. Asia Pacific Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.2. Japan
        • 8.6.2.1. Key Country Dynamics
        • 8.6.2.2. Japan Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.3. China
        • 8.6.3.1. Key Country Dynamics
        • 8.6.3.2. China Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.4. India
        • 8.6.4.1. Key Country Dynamics
        • 8.6.4.2. India Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.5. Australia
        • 8.6.5.1. Key Country Dynamics
        • 8.6.5.2. Australia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.6. South Korea
        • 8.6.6.1. Key Country Dynamics
        • 8.6.6.2. South Korea Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.6.7. Thailand
        • 8.6.7.1. Key Country Dynamics
        • 8.6.7.2. Thailand Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.7. Latin America
      • 8.7.1. Latin America Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.7.2. Brazil
        • 8.7.2.1. Key Country Dynamics
        • 8.7.2.2. Brazil Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033
      • 8.7.3. Argentina
        • 8.7.3.1. Key Country Dynamics
        • 8.7.3.2. Argentina Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
    • 8.8. Middle East & Africa
      • 8.8.1. Middle East & Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.8.2. South Africa
        • 8.8.2.1. Key Country Dynamics
        • 8.8.2.2. South Africa Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.8.3. Saudi Arabia
        • 8.8.3.1. Key Country Dynamics
        • 8.8.3.2. Saudi Arabia Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.8.4. UAE
        • 8.8.4.1. Key Country Dynamics
        • 8.8.4.2. UAE Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)
      • 8.8.5. Kuwait
        • 8.8.5.1. Key Country Dynamics
        • 8.8.5.2. Kuwait Companion Animal Osteoarthritis Market Estimates And Forecasts, 2021 - 2033 (USD Million)

    Chapter 9. Competitive Landscape

    • 9.1. Market Participant Categorization
    • 9.2. Company Market Position Analysis/ Heap Map Analysis
    • 9.3. Company Profiles
      • 9.3.1. Zoetis
        • 9.3.1.1. Participant's Overview
        • 9.3.1.2. Financial Performance
        • 9.3.1.3. Product Benchmarking
        • 9.3.1.4. Strategic Initiatives
      • 9.3.2. Boehringer Ingelheim
        • 9.3.2.1. Participant's Overview
        • 9.3.2.2. Financial Performance
        • 9.3.2.3. Product Benchmarking
        • 9.3.2.4. Strategic Initiatives
      • 9.3.3. Elanco Animal Health
        • 9.3.3.1. Participant's Overview
        • 9.3.3.2. Financial Performance
        • 9.3.3.3. Product Benchmarking
        • 9.3.3.4. Strategic Initiatives
      • 9.3.4. American Regent, Inc.
        • 9.3.4.1. Participant's Overview
        • 9.3.4.2. Financial Performance
        • 9.3.4.3. Product Benchmarking
        • 9.3.4.4. Strategic Initiatives
      • 9.3.5. Merck Animal Health (Merck & Co. Inc)
        • 9.3.5.1. Participant's Overview
        • 9.3.5.2. Financial Performance
        • 9.3.5.3. Product Benchmarking
        • 9.3.5.4. Strategic Initiatives
      • 9.3.6. Vetoquinol S.A.
        • 9.3.6.1. Participant's Overview
        • 9.3.6.2. Financial Performance
        • 9.3.6.3. Product Benchmarking
        • 9.3.6.4. Strategic Initiatives
      • 9.3.7. Ceva Sante Animale
        • 9.3.7.1. Participant's Overview
        • 9.3.7.2. Financial Performance
        • 9.3.7.3. Product Benchmarking
        • 9.3.7.4. Strategic Initiatives
      • 9.3.8. Virbac
        • 9.3.8.1. Participant's Overview
        • 9.3.8.2. Financial Performance
        • 9.3.8.3. Product Benchmarking
        • 9.3.8.4. Strategic Initiatives
      • 9.3.9. Biogenesis Bago
        • 9.3.9.1. Participant's Overview
        • 9.3.9.2. Financial Performance
        • 9.3.9.3. Product Benchmarking
        • 9.3.9.4. Strategic Initiatives
      • 9.3.10. Ardent Animal Health, Llc
        • 9.3.10.1. Participant's Overview
        • 9.3.10.2. Financial Performance
        • 9.3.10.3. Product Benchmarking
        • 9.3.10.4. Strategic Initiatives
      • 9.3.11. PetVivo Holdings, Inc. (Spryng)
        • 9.3.11.1. Participant's Overview
        • 9.3.11.2. Financial Performance
        • 9.3.11.3. Product Benchmarking
        • 9.3.11.4. Strategic Initiatives
      • 9.3.12. VetStem Inc.
        • 9.3.12.1. Participant's Overview
        • 9.3.12.2. Financial Performance
        • 9.3.12.3. Product Benchmarking
        • 9.3.12.4. Strategic Initiatives
      • 9.3.13. Enso Discoveries
        • 9.3.13.1. Participant's Overview
        • 9.3.13.2. Financial Performance
        • 9.3.13.3. Product Benchmarking
        • 9.3.13.4. Strategic Initiatives
      • 9.3.14. Contura Vet US
        • 9.3.14.1. Participant's Overview
        • 9.3.14.2. Financial Performance
        • 9.3.14.3. Product Benchmarking
        • 9.3.14.4. Strategic Initiatives
      • 9.3.15. T-Cyte Therapeutics
        • 9.3.15.1. Participant's Overview
        • 9.3.15.2. Financial Performance
        • 9.3.15.3. Product Benchmarking
        • 9.3.15.4. Strategic Initiatives
      • 9.3.16. Medrego Llc.
        • 9.3.16.1. Participant's Overview
        • 9.3.16.2. Financial Performance
        • 9.3.16.3. Product Benchmarking
        • 9.3.16.4. Strategic Initiatives
    • 9.4. Strategy Mapping
        • 9.4.. Mergers & Acquisitions
      • 9.4.2. Partnerships & Collaborations
      • 9.4.3. Expansion
      • 9.4.4. Product launch
      • 9.4.5. Product Approval
      • 9.4.6. Others
    • 9.5. List of Key Companies
      • 9.5.1. List of Manufacturers
      • 9.5.2. List of Distributors

    List of Tables

    • Table 1 List of Secondary Sources
    • Table 2 List of Abbreviations
    • Table 3 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 4 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 5 Global Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 6 Global Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 7 Global Companion Animal Osteoarthritis Market, by Region, 2021 - 2033 (USD Million)
    • Table 8 North America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 9 North America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 10 North America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 11 North America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 12 North America Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 13 U.S. Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 14 U.S. Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 15 U.S. Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 16 U.S. Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 17 Canada Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 18 Canada Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 19 Canada Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 20 Canada Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 21 Mexico Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 22 Mexico Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 23 Mexico Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 24 Mexico Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 25 Europe Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 26 Europe Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 27 Europe Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 28 Europe Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 29 Europe Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 30 UK Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 31 UK Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 32 UK Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 33 UK Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 34 Germany Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 35 Germany Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 36 Germany Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 37 Germany Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 38 France Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 39 France Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 40 France Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 41 France Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 42 Italy Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 43 Italy Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 44 Italy Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 45 Italy Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 46 Spain Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 47 Spain Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 48 Spain Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 49 Spain Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 50 Denmark Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 51 Denmark Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 52 Denmark Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 53 Denmark Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 54 Sweden Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 55 Sweden Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 56 Sweden Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 57 Sweden Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 58 Norway Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 59 Norway Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 60 Norway Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 61 Norway Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 62 Asia Pacific Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 63 Asia Pacific Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 64 Asia Pacific Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 65 Asia Pacific Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 66 Asia Pacific Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 67 China Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 68 China Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 69 China Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 70 China Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 71 Japan Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 72 Japan Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 73 Japan Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 74 Japan Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 75 India Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 76 India Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 77 India Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 78 India Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 79 South Korea Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 80 South Korea Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 81 South Korea Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 82 South Korea Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 83 Australia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 84 Australia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 85 Australia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 86 Australia Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 87 Thailand Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 88 Thailand Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 89 Thailand Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 90 Thailand Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 91 Latin America Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 92 Latin America Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 93 Latin America Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 94 Latin America Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 95 Latin America Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 96 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 97 Brazil Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 98 Brazil Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 99 Brazil Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 100 Brazil Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 101 Argentina Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 102 Argentina Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 103 Argentina Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 104 Middle East & Africa Companion Animal Osteoarthritis Market, by Country, 2021 - 2033 (USD Million)
    • Table 105 Middle East & Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 106 Middle East & Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 107 Middle East & Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 108 Middle East & Africa Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 109 South Africa Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 110 South Africa Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 111 South Africa Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 112 South Africa Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 113 Saudi Arabia Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 114 Saudi Arabia Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 115 Saudi Arabia Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 116 Saudi Arabia Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 117 UAE Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 118 UAE Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 119 UAE Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 120 UAE Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Table 121 Kuwait Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Table 122 Kuwait Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Table 123 Kuwait Companion Animal Osteoarthritis Market, By Route of Administration, 2021 - 2033 (USD Million)
    • Table 124 Kuwait Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)

    List of Figures

    • Fig. 1 Market research process
    • Fig. 2 Information Procurement
    • Fig. 3 Primary Research Pattern
    • Fig. 4 Market Research Approaches
    • Fig. 5 Value Chain-Based Sizing & Forecasting
    • Fig. 6 Market Formulation & Validation
    • Fig. 7 Companion Animal Osteoarthritis Market, Market Segmentation
    • Fig. 8 Market Driver Relevance Analysis (Current & Future Impact)
    • Fig. 9 Market Restraint Relevance Analysis (Current & Future Impact)
    • Fig. 10 Market Challenge Relevance Analysis (Current & Future Impact)
    • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
    • Fig. 12 Porter's Five Forces Analysis
    • Fig. 13 Regional Marketplace: Key Takeaways
    • Fig. 14 Global Companion Animal Osteoarthritis Market, By Product, 2021 - 2033 (USD Million)
    • Fig. 15 Global Companion Animal Osteoarthritis Market, for Biologics, 2021 - 2033 (USD Million)
    • Fig. 16 Global Companion Animal Osteoarthritis Market, for Stem Cells, 2021 - 2033 (USD Million)
    • Fig. 17 Global Companion Animal Osteoarthritis Market, for Platelet-Rich Plasma (PRP), 2021 - 2033 (USD Million)
    • Fig. 18 Global Companion Animal Osteoarthritis Market, for Monoclonal Antibodies (mAb), 2021 - 2033 (USD Million)
    • Fig. 19 Global Companion Animal Osteoarthritis Market, for Other Biologics, 2021 - 2033 (USD Million)
    • Fig. 20 Global Companion Animal Osteoarthritis Market, for Viscosupplements, 2021 - 2033 (USD Million)
    • Fig. 21 Global Companion Animal Osteoarthritis Market, for Pharmaceuticals, 2021 - 2033 (USD Million)
    • Fig. 22 Global Companion Animal Osteoarthritis Market, for Steroids, 2021 - 2033 (USD Million)
    • Fig. 23 Global Companion Animal Osteoarthritis Market, for NSAIDS, 2021 - 2033 (USD Million)
    • Fig. 24 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
    • Fig. 25 Global Companion Animal Osteoarthritis Market, for Nutritional Supplements, 2021 - 2033 (USD Million)
    • Fig. 26 Global Companion Animal Osteoarthritis Market, By Animal, 2021 - 2033 (USD Million)
    • Fig. 27 Global Companion Animal Osteoarthritis Market, for Canine, 2021 - 2033 (USD Million)
    • Fig. 28 Global Companion Animal Osteoarthritis Market, for Equine, 2021 - 2033 (USD Million)
    • Fig. 29 Global Companion Animal Osteoarthritis Market, for Feline, 2021 - 2033 (USD Million)
    • Fig. 30 Global Companion Animal Osteoarthritis Market, for By Route of Administration, 2021 - 2033 (USD Million)
    • Fig. 31 Global Companion Animal Osteoarthritis Market, for Oral, 2021 - 2033 (USD Million)
    • Fig. 32 Global Companion Animal Osteoarthritis Market, for Injectable, 2021 - 2033 (USD Million)
    • Fig. 33 Global Companion Animal Osteoarthritis Market, for Intra-muscular, 2021 - 2033 (USD Million)
    • Fig. 34 Global Companion Animal Osteoarthritis Market, for Intra-articular, 2021 - 2033 (USD Million)
    • Fig. 35 Global Companion Animal Osteoarthritis Market, for Other Injectable, 2021 - 2033 (USD Million)
    • Fig. 36 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
    • Fig. 37 Global Companion Animal Osteoarthritis Market, By End Use, 2021 - 2033 (USD Million)
    • Fig. 38 Global Companion Animal Osteoarthritis Market, for Veterinary Hospitals/Clinics, 2021 - 2033 (USD Million)
    • Fig. 39 Global Companion Animal Osteoarthritis Market, for E-commerce, 2021 - 2033 (USD Million)
    • Fig. 40 Global Companion Animal Osteoarthritis Market, for Others, 2021 - 2033 (USD Million)
    • Fig. 41 Regional Outlook, 2024 & 2033
    • Fig. 42 North America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 43 U.S. Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 44 Canada Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 45 Mexico Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 46 Europe Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 47 UK Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 48 Germany Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 49 France Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 50 Italy Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 51 Spain Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 52 Sweden Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 53 Denmark Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 54 Norway Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 55 Asia Pacific Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 56 Japan Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 57 China Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 58 India Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 59 Australia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 60 South Korea Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 61 Thailand Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 62 Latin America Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 63 Brazil Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 64 Argentina Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 65 Middle East and Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 66 South Africa Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 67 Saudi Arabia Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 68 UAE Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)
    • Fig. 69 Kuwait Companion Animal Osteoarthritis Market, 2021 - 2033 (USD Million)